PT975783E - "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas" - Google Patents

"vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas"

Info

Publication number
PT975783E
PT975783E PT98916814T PT98916814T PT975783E PT 975783 E PT975783 E PT 975783E PT 98916814 T PT98916814 T PT 98916814T PT 98916814 T PT98916814 T PT 98916814T PT 975783 E PT975783 E PT 975783E
Authority
PT
Portugal
Prior art keywords
retroviral vectors
production
transfer
genes
positive cells
Prior art date
Application number
PT98916814T
Other languages
English (en)
Inventor
Klaus Cichutek
Jorn Stitz
Original Assignee
Bundesrepublik Deu L D P Paul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bundesrepublik Deu L D P Paul filed Critical Bundesrepublik Deu L D P Paul
Priority claimed from DE19808438A external-priority patent/DE19808438A1/de
Publication of PT975783E publication Critical patent/PT975783E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
PT98916814T 1997-02-27 1998-02-27 "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas" PT975783E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19707971 1997-02-27
DE19808438A DE19808438A1 (de) 1997-02-27 1998-02-27 Retrovirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in CD4-positive Zellen

Publications (1)

Publication Number Publication Date
PT975783E true PT975783E (pt) 2002-04-29

Family

ID=26034360

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98916814T PT975783E (pt) 1997-02-27 1998-02-27 "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas"

Country Status (9)

Country Link
US (1) US6902929B1 (pt)
EP (1) EP0975783B1 (pt)
AT (1) ATE207963T1 (pt)
AU (1) AU7028998A (pt)
CA (1) CA2282394C (pt)
DK (1) DK0975783T3 (pt)
ES (1) ES2167072T3 (pt)
PT (1) PT975783E (pt)
WO (1) WO1998038325A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69739351D1 (de) * 1996-12-16 2009-05-20 Eisai R&D Man Co Ltd DNA-Konstrukt umfassend ein Medikamenten-Resistenzgen und ein fremdes Gen
PT975783E (pt) 1997-02-27 2002-04-29 Bundesrepublik Deu L D P Paul "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas"
US8703480B1 (en) * 1997-03-21 2014-04-22 Enzo Therapeutics, Inc. Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells
WO1998042856A1 (en) * 1997-03-21 1998-10-01 Enzo Therapeutics, Inc., A Fully Owned Subsidiary Of Enzo Biochem, Inc. Vectors and viral vectors, and packaging cell lines for propagating same
EP1025208A2 (en) * 1997-10-20 2000-08-09 Universita' Degli Studi Di Padova A packaging cell line producing siv-pseudotyped mlv
US20060183228A1 (en) * 1998-03-24 2006-08-17 Enzo Therapeutics, Inc. Viral vectors with surface or envelope components
AU2003260769A1 (en) * 2002-09-03 2004-03-29 Oxford Biomedica (Uk) Limited Retroviral vector and stable packaging cell lines
US20070037284A1 (en) * 2003-06-04 2007-02-15 Enzo Therapeutics, Inc. Vectors for expressing exogenous gene or exogenous nucleic acid sequences
EP2090659A1 (en) * 2008-02-14 2009-08-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Infectious particle, process for its preparation and use thereof
EP3187585A1 (en) 2010-03-25 2017-07-05 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
PL2691530T3 (pl) 2011-06-10 2019-02-28 Oregon Health & Science University Glikoproteiny i rekombinowane wektory CMV

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727429B1 (fr) 1994-11-30 1997-11-28 Haguenauer Odile Cohen Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs
JPH11502706A (ja) * 1995-03-29 1999-03-09 ババリアン・ノルディック・リサーチ・インスティテュート・アクティーゼルスカブ シュードタイプレトロウイルス粒子
PT975783E (pt) 1997-02-27 2002-04-29 Bundesrepublik Deu L D P Paul "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas"

Also Published As

Publication number Publication date
AU7028998A (en) 1998-09-18
US6902929B1 (en) 2005-06-07
CA2282394C (en) 2006-11-28
EP0975783B1 (de) 2001-10-31
WO1998038325A2 (de) 1998-09-03
DK0975783T3 (da) 2002-01-28
WO1998038325A3 (de) 1998-12-10
ES2167072T3 (es) 2002-05-01
CA2282394A1 (en) 1998-09-03
ATE207963T1 (de) 2001-11-15
EP0975783A2 (de) 2000-02-02

Similar Documents

Publication Publication Date Title
Simm et al. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
GB2331522B (en) Lentiviral vectors
AU7282787A (en) A cell line producing aids viral antigens without producing infectious virus particles
PT975783E (pt) "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas"
EP0702716A4 (en) GENTHERAPY FOR HIV INFECTION AND AIDS WITH THE AID OF RIBOZYMS
EP1035210A3 (de) Von SIVagm abgeleitete lentivirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in Säugerzellen
SI0887427T1 (sl) Pomnozevanje in detekcija HIV-1 in/ali HIV-2
AU7234987A (en) Viral vector coding for a glycoprotein of the virus responsible for a.i.d.s., vaccine and antibody
WO1993017118A3 (en) Defective packaging non-oncoviral vectors based on mpmv and hiv
PT880594E (pt) Vector retroviral e sua utilizacao em terapia genica
WO1999053085A3 (en) Selective regulation of adenovirus production
AU7289587A (en) Immunosuppressive factor from human immunodeficiency virus (hiv) or hiv infected cells or cell lines, its use, corresponding antibodies and their use
DK631387A (da) Virusvektor
WO1999034006A3 (en) A method for the positive selection of cd4+ t-lymphocytes transduced with anti-hiv genes
DE69936464D1 (de) Gp120-mutanten und deren biologische verwendungen
RU94002006A (ru) Штамм культуры клеток человека нтн1 27 - продуцент вируса иммунодефицита человека (вич)
MX9406022A (es) Metodo y reactivo para inhibir la replicacion del virus de inmunodeficiencia humana.